Literature DB >> 7319916

Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3"-O-acyl derivatives of leucomycin.

H Sakakibara, O Okekawa, T Fujiwara, M Aizawa, S Omura.   

Abstract

3"-O-Acylation of leucomycin A5 increased its in vitro antibacterial activity against sensitive microorganisms and also some resistant ones. An increased effect was particularly noted when an acetyl or propionyl group was introduced. On the contrary, acylation of the C-3 and C-9 hydroxyl groups reduced the antibacterial activity in vitro. Introduction of an acyl group at the C-3" hydroxyl group increased the serum level of the compound. The increase in serum level from 3"-O-acylation is higher than that from 3-O-acylation. The serum level of the 3"-O-propionyl derivative of leucomycin A5 was higher than that of the 3"-O-acetyl derivative. 3"-O-Propionylleucomycin A5 (5) was the derivative that showed the highest antibacterial activity and yielded the highest serum level among the derivatives examined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7319916     DOI: 10.7164/antibiotics.34.1011

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  In vitro susceptibility of Campylobacter jejuni to rokitamycin.

Authors:  Y Miyake; M Okada; M Sasaki; N Nagasaka; H Suginaka
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

3.  Dinuclear vs. Mononuclear Copper(II) Coordination Species of Tylosin and Tilmicosin in Non-Aqueous Solutions.

Authors:  Ivayla Pantcheva; Radoslava Stamboliyska; Nikolay Petkov; Alia Tadjer; Svetlana Simova; Radostina Stoyanova; Rositza Kukeva; Petar Dorkov
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

Review 4.  New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

5.  Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.

Authors:  T Misu; S Arai; M Furukawa; Y Yamamoto; T Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.